Pharmacogenetic vs. Concentration-Controlled Optimization of Tacrolimus Dosing in Renal Allograft Recipients

被引：8
|
作者：
Kuypers, D. R. J. [1 ]
机构：
[1] Univ Hosp Leuven, Dept Nephrol & Renal Transplantat, Louvain, Belgium
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 88卷 / 05期
关键词：
D O I：
10.1038/clpt.2010.129
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：595 / 596
页数：2
相关论文
共 50 条
  • [31] Generic Tacrolimus Based Immunosuppression among Renal Allograft Recipients in India
    Basu, G.
    Annapandian, V. M.
    Mathew, B. S.
    Saravanakumar, K.
    Kumaravel, S. G.
    Mohapatra, A.
    David, V. G.
    Alexander, S.
    Valson, A. T.
    Varughese, S.
    Fleming, D. H.
    Jacob, C. K.
    Tamilarasi, V
    John, G. T.
    TRANSPLANTATION, 2012, 94 (10) : 595 - 595
  • [32] Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial
    van Gelder, Tenn
    Silva, Helio Tedesco
    de Fijter, Johan W.
    Budde, Klemens
    Kuypers, Dirk
    Tyden, Gunnar
    Lohmus, Aleksander
    Sommerer, Claudia
    Hartmann, Anders
    Le Meur, Yann
    Oellerich, Michael
    Holt, David W.
    Toenshoff, Burkhard
    Keown, Paul
    Campbell, Scott
    Mamelok, Richard D.
    TRANSPLANTATION, 2008, 86 (08) : 1043 - 1051
  • [33] Comparison of Dose-Finding Designs for Narrow-Therapeutic-Index Drugs: Concentration-Controlled vs. Dose-Controlled Trials
    Lledo-Garcia, R.
    Hennig, S.
    Karlsson, M. O.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (01) : 62 - 69
  • [34] Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients
    Khaled Benkali
    Aurelie Prémaud
    Nicolas Picard
    Jean-Philippe Rérolle
    Olivier Toupance
    Guillaume Hoizey
    Alain Turcant
    Florence Villemain
    Yannick Le Meur
    Pierre Marquet
    Annick Rousseau
    Clinical Pharmacokinetics, 2009, 48 : 805 - 816
  • [35] Malignancies in de novo renal transplant recipients using branded cyclosporine microemulsion (BCSA) vs. tacrolimus
    Legorreta, Antonio P.
    Robinson, Matthew L.
    Gilmore, Amanda S.
    Ryskina, Kira L.
    Naujoks, Christel
    TRANSPLANT INTERNATIONAL, 2007, 20 : 136 - 136
  • [36] Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients
    Benkali, Khaled
    Premaud, Aurelie
    Picard, Nicolas
    Rerolle, Jean-Philippe
    Toupance, Olivier
    Hoizey, Guillaume
    Turcant, Alain
    Villemain, Florence
    Le Meur, Yannick
    Marquet, Pierre
    Rousseau, Annick
    CLINICAL PHARMACOKINETICS, 2009, 48 (12) : 805 - 816
  • [37] COMPUTER-ASSISTED TACROLIMUS DOSING IMPROVE TARGET CONCENTRATION ACHIEVEMENT IN RENAL TRANSPLANT RECIPIENTS - A PROSPECTIVE RANDOMIZED STUDY
    Asberg, Anders
    Storset, Elisabet
    Skauby, Morten
    Neely, Michael
    Bergan, Stein
    Bremer, Sara
    Midtvedt, Karsten
    TRANSPLANT INTERNATIONAL, 2015, 28 : 203 - 203
  • [38] Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients-A Prospective, Randomized Study
    Storset, Elisabet
    Asberg, Anders
    Skauby, Morten
    Neely, Michael
    Bergan, Stein
    Bremer, Sara
    Midtvedt, Karsten
    TRANSPLANTATION, 2015, 99 (10) : 2158 - 2166
  • [39] Significant impact of gene polymorphism on tacrolimus and sirolimus dosing in renal transplant recipients
    Loh, P. T.
    Lou, H. X.
    Zhao, Y.
    Chin, Y. M.
    Vathsala, A.
    NEPHROLOGY, 2008, 13 : A20 - A20
  • [40] Influence of CYP3A5 and ABCB1 Polymorphism on Tacrolimus Drug Dosing in South Indian Renal Allograft Recipients
    Fernando, M. Edwin
    Sellappan, Manokaran
    Prasad, N. D. Srinivasa
    Suren, Sujit
    Thirumalvalavan, K.
    INDIAN JOURNAL OF NEPHROLOGY, 2019, 29 (04) : 261 - 266
12345